As filed with the Securities and Exchange Commission on March 16,
2023
Registration
No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER THE
SECURITIES ACT OF 1933
ACHIEVE LIFE SCIENCES, INC.
(Exact name of Registrant as specified in its charter)
|
|
|
Delaware
|
|
95-4343413
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
|
|
|
|
1040 West Georgia Street, Suite 1030
Vancouver, BC
|
V6E 4H1
|
(Address of principal executive offices)
|
(Zip Code)
|
2018 Equity Incentive Plan
2017 Employee Stock Purchase Plan
Non-Plan Stock Option Agreements (Inducement Stock Option
Awards)
(Full title of the plan)
John Bencich
Chief Executive Officer
1040 West Georgia Street, Suite 1030
Vancouver, BC V6E 4H1
(Name and address of agent for service)
(604) 210-2217
(Telephone number, including area code, or agent for service)
Please send copies of all communications to:
Alan Smith, Esq.
Amanda Rose, Esq.
Chelsea Anderson, Esq.
Fenwick & West LLP
1191 Second Avenue, Floor 10
Seattle, WA 98101
(206) 389-4510
Indicate by check mark whether the Registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule
12b-2 of the Exchange Act.
Large accelerated filer
|
|
☐
|
|
Accelerated filer
|
|
☐
|
Non-accelerated filer
|
|
☒
|
|
Smaller reporting company
|
|
☒
|
|
|
|
|
Emerging growth company
|
|
☐
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the
Securities Act. ☐
INTRODUCTORY NOTE
REGISTRATION OF ADDITIONAL SHARES PURSUANT TO GENERAL INSTRUCTION
E
Pursuant to General Instruction E of Form S-8, Achieve Life
Sciences, Inc. (the “Registrant”) is filing
this Registration Statement on Form S-8 (the “Registration
Statement”) with the Securities and Exchange Commission (the
“Commission”) to
register (a) 894,851 additional shares of common stock under the
Registrant’s 2018 Equity Incentive Plan (“EIP”), pursuant to the
provisions of the EIP providing for an automatic increase in the
number of shares reserved for issuance under the EIP on
January 1, 2023, (b) 178,970 additional shares of common stock
under the Registrant’s 2017 Employee Stock Purchase Plan
(“ESPP”),
pursuant to the provisions of the ESPP providing for an automatic
increase in the number of shares reserved for issuance under the
ESPP on January 1, 2023 and (c) 55,000 additional shares of common
stock granted by the Registrant to certain employees as a material
inducement to their acceptance of employment with the Registrant in
accordance with Nasdaq Listing Rule 5635(c)(4). This Registration
Statement hereby incorporates by reference the contents of the
Registrant’s previous registration statement on Form S-8 filed with
the Commission on March 10, 2022 (Registration No.
333-263421)
to the extent not superseded hereby.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.
|
Incorporation of Documents by Reference.
|
The following documents filed by the Registrant with the Commission
pursuant to the Securities Act and the Securities Exchange Act of
1934, as amended (the “Exchange Act”) are
incorporated herein by reference:
|
(a)
|
the Registrant’s
Annual Report on Form
10-K
for the fiscal year ended December 31, 2022, filed with the
Commission March 16, 2023 pursuant to Section 13 of the Exchange
Act;
|
|
(b)
|
all other reports filed pursuant to Section 13(a) or 15(d) of
the Exchange Act since the end of the fiscal year covered by the
Registrant’s Annual Report referred to in (a) above; and
|
|
(c)
|
the description of the Registrant’s common stock contained in the
Company’s Registration Statement on Form 8-A filed with the
Commission on September 27, 1995 (paper filing), pursuant to
Section 12(b) of the Exchange Act, including any other
amendments or reports filed for the purpose of updating such
description.
|
All documents filed by the Registrant pursuant to
Section 13(a), 13(c), 14 or 15(d) of the Exchange Act
subsequent to the filing of this Registration Statement and prior
to the filing of a post-effective amendment which indicates that
all securities offered hereby have been sold or which deregisters
all securities then remaining unsold, shall be deemed to be
incorporated by reference into this Registration Statement and to
be a part hereof from the date of filing such documents, except as
to specific sections of such documents as set forth therein. Any
statement contained in a document incorporated or deemed to be
incorporated by reference herein shall be deemed to be modified or
superseded for purposes of this Registration Statement to the
extent that a statement contained in any subsequently filed
document which also is deemed to be incorporated by reference
herein modifies or supersedes such statement.
The following exhibits are filed herewith:
Item 9. Undertakings.
|
A.
|
The undersigned
Registrant hereby undertakes:
|
1)To
file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration Statement:
|
i.
|
To include any
prospectus required by Section 10(a)(3) of the Securities
Act;
|
ii.To
reflect in the prospectus any facts or events arising after the
effective date of the Registration Statement (or the most recent
post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set
forth in the Registration Statement. Notwithstanding the
foregoing, any increase or decrease in the volume of securities
offered (if the total dollar value of securities offered would not
exceed that which was registered) and any deviation from the low or
high end of the estimated maximum offering range may be reflected
in the form of prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and price
represent no more than a 20 percent change in the maximum aggregate
offering price set forth in the “Calculation of Registration Fee”
table in the effective Registration Statement;
iii.To
include any material information with respect to the plan of
distribution not previously disclosed in the Registration Statement
or any material change to such information in the Registration
Statement;
provided,
however, that
paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if the
information required to be included in a post-effective amendment
by those paragraphs is contained in reports filed with or furnished
to the Commission by the Registrant pursuant to Section 13 or
Section 15(d) of the Exchange Act that are incorporated by
reference in the Registration Statement.
2)That,
for the purpose of determining any liability under the Securities
Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to
be the initial bona fide offering thereof.
3)To
remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the
termination of the offering.
B.The
undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of
the Registrant’s annual report pursuant to Section 13(a) or Section
15(d) of the Exchange Act (and, where applicable, each filing of an
employee benefit plan’s annual report pursuant to Section 15(d) of
the Exchange Act) that is incorporated by reference in the
Registration Statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof.
Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and
controlling persons of the Registrant pursuant to the foregoing
provisions, or otherwise, the Registrant has been advised that in
the opinion of the Commission such indemnification is against
public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by
the Registrant of expenses incurred or paid by a director, officer
or controlling person of the Registrant in the successful defense
of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities
being registered hereby, the Registrant will, unless in the opinion
of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by
the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act, the Registrant
certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-8 and has duly caused
this Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Vancouver,
Province of British Columbia, on this 16th day of
March, 2023.
|
|
|
ACHIEVE LIFE SCIENCES, INC.
|
|
|
By:
|
|
/s/ John Bencich
|
|
|
John Bencich
Chief Executive Officer
|
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears
below hereby constitutes and appoints John Bencich and Richard
Stewart, and each of them, as his true and lawful attorney-in-fact
and agent with full power of substitution, for him in any and all
capacities, to sign any and all amendments (including
post-effective amendments) to this Registration Statement on Form
S-8, and to file the same, with all exhibits thereto and other
documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorney-in-fact and agent full
power and authority to do and perform each and every act and thing
requisite and necessary to be done in connection therewith, as
fully for all intents and purposes as he might or could do in
person, hereby ratifying and confirming all that said
attorney-in-fact and agent, or his substitute, may lawfully do or
cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act.
Name
|
|
Title
|
|
Date
|
|
|
|
/s/ John Bencich
John Bencich
|
|
Chief Executive Officer and Director
(Principal Executive Officer and Principal Financial Officer)
|
|
March 16, 2023
|
|
|
|
/s/ Jerry Wan
Jerry Wan
|
|
Senior Director of Accounting Operations
(Principal Accounting Officer)
|
|
March 16, 2023
|
|
|
|
/s/ Richard Stewart
Richard Stewart
|
|
Executive Chairman and Director
|
|
March 16, 2023
|
|
|
|
/s/ Cindy Jacobs
Cindy Jacobs
|
|
Chief Medical Officer and Director
|
|
March 16, 2023
|
|
|
|
/s/ Donald R. Joseph
Donald R. Joseph
|
|
Director
|
|
March 16, 2023
|
|
|
|
/s/ Martin Mattingly
Martin Mattingly
|
|
Director
|
|
March 16, 2023
|
|
|
|
/s/ Bridget Martell
Bridget Martell
|
|
Director
|
|
March 16, 2023
|
|
|
|
/s/ Jay M. Moyes
Jay M. Moyes
|
|
Director
|
|
March 16, 2023
|
|
|
|
/s/ Vaughn Himes
Vaugh Himes
|
|
Director
|
|
March 16, 2023
|
Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
Von Apr 2023 bis Mai 2023
Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
Von Mai 2022 bis Mai 2023